Pazeo and Revlimid drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Pazeo (olopatadine hydrochloride) and Revlimid (lenalidomide). Common drug interactions include fatigue among females and pruritus among males.
The phase IV clinical study analyzes what interactions people have when they take Pazeo and Revlimid. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.
What is Pazeo?
Pazeo has active ingredients of olopatadine hydrochloride. eHealthMe is studying from 1,256 Pazeo users. Check the latest studies of Pazeo.
What is Revlimid?
Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.
44 people who take Pazeo and Revlimid together, and have interactions are studied.
What are the common drug interactions of Pazeo and Revlimid, by gender? *:
female:
- Fatigue (feeling of tiredness)
- Bone density decreased
- Rash
- Diarrhoea
- Arthralgia (joint pain)
- Tooth disorder (tooth disease)
- Cyst (a closed sac)
- Fall
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Phlebitis (inflammation of the walls of a vein)
male:
- Pruritus (severe itching of the skin)
- Fatigue (feeling of tiredness)
- Fall
- Upper limb fracture
- Neutropenia (an abnormally low number of neutrophils)
- Gastric ph decreased
- Vomiting
- Decreased appetite
- Diarrhoea
- Dry mouth
What are the common drug interactions of Pazeo and Revlimid, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Eye irritation
- Eyelid margin crusting (crusting at the lid margins, generally worse on waking)
- Eyelids pruritus (eyelids itching)
60+:
- Nasopharyngitis (inflammation of the nasopharynx)
- Weight decreased
- Arthralgia (joint pain)
- Back pain
- Memory impairment
- White blood cell count decreased
- Anxiety
- Blood immunoglobulin g increased
- Decreased appetite
- Diarrhoea
What are the existing conditions these people have? *
- Osteoporosis (bones weak and more likely to break): 3 people, 6.82%
* Approximation only. Some reports may have incomplete information.
Do you take Pazeo and Revlimid?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Pazeo and Revlimid:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pazeo:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Revlimid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pazeo and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Revlimid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on olopatadine hydrochloride and lenalidomide (the active ingredients of Pazeo and Revlimid, respectively), and Pazeo and Revlimid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Escitalopram Oxalate and Latuda - 4 seconds ago
- Drug interactions of Procardia Xl and Hctz - 4 seconds ago
- Could Reglan cause Uterine Haemorrhage? - 13 seconds ago
- Drug interactions of Suboxone and Belsomra - 14 seconds ago
- Could Lipitor cause Asplenia? - 18 seconds ago
- Could Amlodipine cause Eye Burns? - 25 seconds ago
- Drug interactions of Risperdal and Bisacodyl - 29 seconds ago
- Could Tacrolimus cause Recurrent Cancer? - 35 seconds ago
- Stress And Anxiety and Polymyalgia Rheumatica Aggravated - 39 seconds ago
- Drug interactions of Niacin and Cisplatin - 41 seconds ago